Finance entity
markets is the sole category represented across all 1 tracked stories. 60 Largest U.S. Trading Partners is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. U.S. Pharmaceutical Industry appears in 1 tracked Finance story from July 24, 2026.
Last mentioned: Jul 24, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
markets is the sole category represented across all 1 tracked stories. 60 Largest U.S. Trading Partners is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. U.S. Pharmaceutical Industry appears in 1 tracked Finance story from July 24, 2026. The tracked stories average 6 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering U.S. Pharmaceutical Industry. Shared-story counts are live from our verified record — not editorial picks.
The swift replacement of a struck-down tariff regime with new 10% and 12.5% levies on America's 60 biggest trade partners, combined with Canadian fees and pharma threats, introduces heightened policy risk into financial markets. Investors must now price in the probability of further executive action, retaliatory measures, and second-order inflation effects.
U.S. Pharmaceutical Industry is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
